Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas M McCarty

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Plos One|October 11, 2012
Peripheral nervous system neuropathology and progressive sensory impairments in a mouse model of Mucopolysaccharidosis IIIBHaiyan Fu, Julianne D Bartz, Robert L Stephens, et al.
The Journal of Gene Medicine|July 7, 2010
Restoration of central nervous system alpha-N-acetylglucosaminidase activity and therapeutic benefits in mucopolysaccharidosis IIIB mice by a single intracisternal recombinant adeno-associated viral type 2 vector deliveryHaiyan Fu, Julianne DiRosario, Lu Kang, et al.
Journal of Virology|November 12, 2003
Development and characterization of novel empty adenovirus capsids and their impact on cellular gene expressionJackie L Stilwell, Douglas M McCarty, Atsuko Negishi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 2, 2017
Near-Complete Correction of Profound Metabolomic Impairments Corresponding to Functional Benefit in MPS IIIB Mice after IV rAAV9-hNAGLU Gene DeliveryHaiyan Fu, Aaron S Meadows, Tierra Ware, et al.
Glycobiology|June 25, 2004
Analysis of the interaction between adeno-associated virus and heparan sulfate using atomic force microscopyAtsuko Negishi, Jinghua Chen, Douglas M McCarty, et al.
Journal of Neuroinflammation|July 20, 2010
Mucopolysaccharidosis IIIB, a lysosomal storage disease, triggers a pathogenic CNS autoimmune responseSmruti Killedar, Julianne Dirosario, Erin Divers, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2003
Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brainHaiyan Fu, Joseph Muenzer, Richard J Samulski, et al.
Metabolic Brain Disease|April 7, 2017
Serum global metabolomics profiling reveals profound metabolic impairments in patients with MPS IIIA and MPS IIIBHaiyan Fu, Aaron S Meadows, Ricardo J Pineda, et al.
Molecular Therapy. Methods & Clinical Development|March 28, 2017
Effective Depletion of Pre-existing Anti-AAV Antibodies Requires Broad Immune TargetingVictoria M Velazquez, Aaron S Meadows, Ricardo J Pineda, et al.
Plos One|November 27, 2013
Amyloidosis, synucleinopathy, and prion encephalopathy in a neuropathic lysosomal storage disease: the CNS-biomarker potential of peripheral bloodBartholomew J Naughton, F Jason Duncan, Darren Murrey, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Plos One|October 11, 2012
Peripheral nervous system neuropathology and progressive sensory impairments in a mouse model of Mucopolysaccharidosis IIIBHaiyan Fu, Julianne D Bartz, Robert L Stephens, et al.
The Journal of Gene Medicine|July 7, 2010
Restoration of central nervous system alpha-N-acetylglucosaminidase activity and therapeutic benefits in mucopolysaccharidosis IIIB mice by a single intracisternal recombinant adeno-associated viral type 2 vector deliveryHaiyan Fu, Julianne DiRosario, Lu Kang, et al.
Journal of Virology|November 12, 2003
Development and characterization of novel empty adenovirus capsids and their impact on cellular gene expressionJackie L Stilwell, Douglas M McCarty, Atsuko Negishi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 2, 2017
Near-Complete Correction of Profound Metabolomic Impairments Corresponding to Functional Benefit in MPS IIIB Mice after IV rAAV9-hNAGLU Gene DeliveryHaiyan Fu, Aaron S Meadows, Tierra Ware, et al.
Glycobiology|June 25, 2004
Analysis of the interaction between adeno-associated virus and heparan sulfate using atomic force microscopyAtsuko Negishi, Jinghua Chen, Douglas M McCarty, et al.
Journal of Neuroinflammation|July 20, 2010
Mucopolysaccharidosis IIIB, a lysosomal storage disease, triggers a pathogenic CNS autoimmune responseSmruti Killedar, Julianne Dirosario, Erin Divers, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2003
Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brainHaiyan Fu, Joseph Muenzer, Richard J Samulski, et al.
Metabolic Brain Disease|April 7, 2017
Serum global metabolomics profiling reveals profound metabolic impairments in patients with MPS IIIA and MPS IIIBHaiyan Fu, Aaron S Meadows, Ricardo J Pineda, et al.
Molecular Therapy. Methods & Clinical Development|March 28, 2017
Effective Depletion of Pre-existing Anti-AAV Antibodies Requires Broad Immune TargetingVictoria M Velazquez, Aaron S Meadows, Ricardo J Pineda, et al.
Plos One|November 27, 2013
Amyloidosis, synucleinopathy, and prion encephalopathy in a neuropathic lysosomal storage disease: the CNS-biomarker potential of peripheral bloodBartholomew J Naughton, F Jason Duncan, Darren Murrey, et al.
Pageof 4